These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 8402423

  • 1. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F, Bruneau J, Coates R, Rankin JG, Soto J, Arshinoff R, Brabant M, Vincelette J, Fauvel M.
    CMAJ; 1993 Oct 01; 149(7):945-51. PubMed ID: 8402423
    [Abstract] [Full Text] [Related]

  • 2. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S, Panda S, Sarkar K, Hangzo CZ, Bijaya L, Singh NY, Das N, Agarwal A, Chatterjee A, Deb BC.
    Indian J Public Health; 1995 Oct 01; 39(3):86-92. PubMed ID: 8690497
    [Abstract] [Full Text] [Related]

  • 3. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC, Friedman SR.
    AIDS; 1987 Jul 01; 1(2):67-76. PubMed ID: 3130084
    [Abstract] [Full Text] [Related]

  • 4. Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.
    Alary M, Joly JR, Parent R, Fauvel M, Dionne M.
    CMAJ; 1994 Oct 01; 151(7):975-81. PubMed ID: 7922933
    [Abstract] [Full Text] [Related]

  • 5. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
    Bull Narc; 1993 Oct 01; 45(1):19-46. PubMed ID: 8305904
    [Abstract] [Full Text] [Related]

  • 6. HIV prevalence among injection drug users in rural Guangxi China.
    Liu W, Chen J, Rodolph M, Beauchamp G, Mâsse B, Wang S, Li R, Ruan Y, Zhou F, Leung MK, Lai S, Shao Y, Jackson JB.
    Addiction; 2006 Oct 01; 101(10):1493-8. PubMed ID: 16968351
    [Abstract] [Full Text] [Related]

  • 7. Seroprevalence and demographic characteristics of injection drugs users among individuals at risk for HIV infection in Winnipeg, Manitoba, Canada.
    Hammond GW, Tate R, Buchanan D, Malazdrewicz R, Chochinov D, Sekla L, Elmslie K.
    Clin Invest Med; 1991 Oct 01; 14(5):437-43. PubMed ID: 1742922
    [Abstract] [Full Text] [Related]

  • 8. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML, González-Quintela A, Aguilera A, Carballo E, Barrio E.
    Hepatogastroenterology; 2003 Oct 01; 50(54):2093-7. PubMed ID: 14696471
    [Abstract] [Full Text] [Related]

  • 9. HIV antibodies among intravenous drug users in Bahrain.
    al-Haddad MK, Khashaba AS, Baig BZ, Khalfan S.
    J Commun Dis; 1994 Sep 01; 26(3):127-32. PubMed ID: 7868834
    [Abstract] [Full Text] [Related]

  • 10. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
    Lima ES, Bastos FI, Telles PR, Friedman SR.
    Bull Narc; 1993 Sep 01; 45(1):107-15. PubMed ID: 8305901
    [Abstract] [Full Text] [Related]

  • 11. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.
    Nelson KE, Vlahov D, Solomon L, Cohn S, Muñoz A.
    Arch Intern Med; 1995 Jun 26; 155(12):1305-11. PubMed ID: 7778962
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for HIV seropositivity among people consulting for HIV antibody testing: a pilot surveillance study in Quebec.
    Alary M, Castel J.
    CMAJ; 1990 Jul 01; 143(1):25-31. PubMed ID: 2357678
    [Abstract] [Full Text] [Related]

  • 13. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L, Wade A, Persoz A, Boué F, Dellamonica P, Caroli-Bosc C, Carré N.
    Rev Epidemiol Sante Publique; 1998 Feb 01; 46(1):34-9. PubMed ID: 9533232
    [Abstract] [Full Text] [Related]

  • 14. The spread of HIV-1 infection in Italy: seropositivity and AIDS related syndromes.
    Luzi G, Greco D, Sasse H, Rezza G, Aiuti F.
    Allergol Immunopathol (Madr); 1991 Feb 01; 19(1):19-24. PubMed ID: 1950940
    [Abstract] [Full Text] [Related]

  • 15. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.
    AIDS; 1992 Apr 01; 6(4):421-6. PubMed ID: 1616637
    [Abstract] [Full Text] [Related]

  • 16. HIV/AIDS risk perception, HIV risk behaviors, and HIV seropositivity among injection drug users in Puerto Rico.
    Cancel LI, Robles RR, Colón HM, Matos TD, Freeman DH.
    P R Health Sci J; 1994 Jun 01; 13(2):153-8. PubMed ID: 7938402
    [Abstract] [Full Text] [Related]

  • 17. Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and northern Italy, 1987-1989.
    Nicolosi A, Musicco M, Saracco A, Molinari S, Ziliani N, Lazzarin A.
    Epidemiology; 1990 Nov 01; 1(6):453-9. PubMed ID: 2090283
    [Abstract] [Full Text] [Related]

  • 18. HIV risk behaviors and HIV seropositivity among young injection drug users.
    Marrero Rodríguez CA, Robles RR, Colón HM, Freeman DH, Matos TD, Reyes JC.
    P R Health Sci J; 1993 Apr 01; 12(1):7-12. PubMed ID: 8511250
    [Abstract] [Full Text] [Related]

  • 19. Crack cocaine: a risk factor for human immunodeficiency virus infection type 1 among inner-city parturients.
    Lindsay MK, Peterson HB, Boring J, Gramling J, Willis S, Klein L.
    Obstet Gynecol; 1992 Dec 01; 80(6):981-4. PubMed ID: 1448268
    [Abstract] [Full Text] [Related]

  • 20. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B, Narayanan S, Navaratnam V.
    Drug Alcohol Rev; 2009 Jul 01; 28(4):447-54. PubMed ID: 19594801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.